Reproductive Health Care Intervention for Young Female Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help young female cancer survivors engage more effectively in reproductive health care that aligns with their personal goals. It includes a multi-part intervention to enhance how these survivors participate in health care related to their reproductive needs. Women diagnosed with cancer (any stage), who speak English or Spanish, and receive care at a participating rural oncology clinic in Imperial County, California, may be eligible. However, women who are pregnant at the time of recruitment are not eligible. As an unphased trial, this study provides a unique opportunity to contribute to research that could improve reproductive health care for future cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this multi-component reproductive health care intervention is safe for young female cancer survivors?
Research has shown that multi-part reproductive health care programs are generally safe and well-received. Studies on similar programs for young breast cancer survivors in underserved areas have not identified any major safety issues. These programs aim to enhance reproductive health and quality of life, with no significant problems reported.
Although this specific trial lacks detailed safety data at present, it emphasizes encouraging participation in reproductive health care, indicating a supportive rather than risky approach. This design aims to assist rather than introduce new risks. For those considering joining this study, existing evidence from similar research suggests the program is safe.1234Why are researchers excited about this trial?
Researchers are excited about this reproductive health care intervention for young female cancer survivors because it offers a comprehensive, multi-component approach that current options don't typically provide. Unlike standard treatments that often focus on one aspect of reproductive health, this intervention integrates various components to address the unique reproductive challenges faced by cancer survivors. This holistic method aims to improve both the quality and accessibility of reproductive health care, potentially leading to better long-term outcomes for these patients.
What evidence suggests that this multi-component intervention is effective for improving reproductive health care engagement in young female cancer survivors?
Research has shown that combining several methods can enhance reproductive health care for young female cancer survivors. This trial will provide participants with a multi-component reproductive health care intervention, including education, referrals, and consultations to connect patients with fertility resources related to cancer. For instance, one study using telehealth found that scheduling and consultations through electronic health records increased patient involvement in fertility care. Another study found these methods particularly beneficial in resource-limited areas, improving access to reproductive health services. Overall, this evidence suggests that using multiple methods together can significantly improve reproductive health for young female cancer survivors.12356
Who Is on the Research Team?
H. Irene Su, MD, MSCE
Principal Investigator
University of California, San Diego
Are You a Good Fit for This Trial?
This trial is for young female cancer survivors living in Imperial County, California. They must have been diagnosed with cancer at any stage from 0-IV and be receiving care at a rural oncology clinic participating in the study. Participants need to speak English or Spanish but cannot join if they are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-component intervention to improve engagement in goal-concordant reproductive health care
Follow-up
Participants are monitored for engagement in reproductive health care after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Multi-component reproductive health care intervention
Multi-component reproductive health care intervention is already approved in European Union, United States for the following indications:
- Ovarian cancer
- Breast cancer
- Fallopian tube cancer
- Peritoneal cancer
- Pancreatic cancer
- Prostate cancer
- Ovarian cancer
- Breast cancer
- Fallopian tube cancer
- Peritoneal cancer
- Pancreatic cancer
- Prostate cancer
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Diego
Lead Sponsor
Cancer Resource Center of the Desert
Collaborator
El Centro Regional Medical Center
Collaborator
National Cancer Institute (NCI)
Collaborator
San Diego State University
Collaborator